Latest news
Myriad Genetics (NASDAQ:MYGN) Lowered to "Sell" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:47:17 GMTMyriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Fri, 07 Aug 2026 23:44:17 GMTState Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics - Stock TitanStock Titan · Fri, 07 Aug 2026 14:10:28 GMTBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Stockholders to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Fri, 07 Aug 2026 09:08:07 GMTMYGN Aug 2026 8.000 call (MYGN260821C00008000) stock historical prices and data - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 07:21:37 GMTMyriad Genetics (NASDAQ:MYGN) Lowered to Strong Sell Rating by Zacks Research - MarketBeatMarketBeat · Thu, 06 Aug 2026 12:10:35 GMTMYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN) - Business WireBusiness Wire · Wed, 05 Aug 2026 14:07:00 GMTMyriad Genetics, Inc. (MYGN) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Tue, 04 Aug 2026 20:33:45 GMT